Francesco Lombardo

Dr. Francesco Lombardo


Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2017 in Endocrine
Verified
Journal Article
Closed access
PDF file
FLFrancesca Lolli
Francesca Lolli
FPFrancesco Pallotti
Francesco Pallotti
ARAlfredo Rossi
Alfredo Rossi
MFMaria C. Fortuna
Maria C. Fortuna
GCGemma Caro
Gemma Caro
FLFrancesco Lombardo
Francesco Lombardo

22 April 2004 in Human Reproduction
Verified
Journal Article
Closed access
PDF file
LGL. Gandini
L. Gandini
FLFrancesco Lombardo
Francesco Lombardo
Donatella PaoliDonatella Paoli
Donatella Paoli
FCF. Caruso
F. Caruso
PEP. Eleuteri
P. Eleuteri
MSM. Spanò
M. Spanò
BACKGROUND: Sperm DNA integrity is essential for the accurate transmission of genetic information. The clinical significance of this assessment lies in its association with not only natural conception rates, but also the success of assisted reproduction technology (ART). It has been reported that sperm chromatin structure assay (SCSA) identified thresholds for negative pregnancy outcome after ART when the DNA fragmentation index (DFI), previously known as COMPαt, was >30%. METHODS: In a prospective clinical study, we examined 34 male infertile patients, the husbands of women undergoing conventional IVF or ICSI. SCSA and ART were carried out on semen aliquots taken from the same ejaculate. Fertilization rate, embryo quality and pregnancy rates were correlated to SCSA parameters, DFI and highly DNA stainable (HDS) cells. RESULTS: No differences were seen in SCSA parameter values between patients initiating pregnancies and not doing so in either ICSI or conventional IVF. Pregnancies and normal delivery were obtained even with high levels of DFI. CONCLUSIONS: There is still controversy over whether analytical techniques currently in use are able to identify the level of damage to spermatozoa. Large‐scale studies should be conducted in different clinical settings to determine the effects of sperm DNA damage on the outcome of ART.

1 June 2004 in Fertility and Sterility
Verified
Journal Article
Closed access
ALAndrea Lenzi
Andrea Lenzi
Paolo SgròPaolo Sgrò
Paolo Sgrò
PSPietro Salacone
Pietro Salacone
Donatella PaoliDonatella Paoli
Donatella Paoli
BGBarbara Gilio
Barbara Gilio
LGLoredana Gandini
Loredana Gandini

1 April 2000 in Human Reproduction
Verified
Journal Article
Open access
PDF file
LGLoredana Gandini
Loredana Gandini
FLFrancesco Lombardo
Francesco Lombardo
Donatella PaoliDonatella Paoli
Donatella Paoli
LCLuisa Caponecchia
Luisa Caponecchia
GFGiuseppe Familiari
Giuseppe Familiari
ALAndrea Lenzi
Andrea Lenzi
The aim of our work was to define and better understand apoptosis in the spermatozoa of normal subjects, infertile patients and patients affected by specific tumoral diseases employing the method of the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling and confirming the results by electron microscopy. We studied 23 healthy, normozoospermic subjects (group A), 29 oligoasthenoteratozoospermic patients, affected by various andrological pathologies (group B), 28 patients with Hodgkin's disease (C1) and 30 patients with testicular cancer (C2). Our data demonstrate that the percentage of apoptosis in normozoospermic subjects (group A) is significantly lower than in all the other groups (B, C1, C2) (P < 0.001). This confirms that high DNA fragmentation is one of the characteristics of spermatogenetic failure. The induction of apoptosis, which can also be a basic response to neoplastic disease, can even act right up to the mature male gamete. Our results suggest that apoptosis could be the final result of various pathologies and of a deregulation of spermatogenesis control systems.

1 February 2003 in Fertility and Sterility
Verified
Journal Article
Closed access
ALAndrea Lenzi
Andrea Lenzi
FLFrancesco Lombardo
Francesco Lombardo
Paolo SgròPaolo Sgrò
Paolo Sgrò
PSPietro Salacone
Pietro Salacone
LCLuisa Caponecchia
Luisa Caponecchia
LGLoredana Gandini
Loredana Gandini

23 April 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Open access
PDF file
Donatella PaoliDonatella Paoli
Donatella Paoli
FPFrancesco Pallotti
Francesco Pallotti
SCS. Colangelo
S. Colangelo
FBFabrizio Basilico
Fabrizio Basilico
LML. Mazzuti
L. Mazzuti
FLFrancesco Lombardo
Francesco Lombardo
Introduction The recent appearance of SARS-CoV-2 in Wuhan in 2019 has started a pandemic which has involved over a million people worldwide. A matter of debate is the possible viral detection in different body fluids than respiratory droplets. Thus, we evaluated the possible presence of SARS-CoV-2 in semen and urine samples of a volunteer with confirmed COVID-19. Materials and methods A 31-year-old man with fever, myalgia, anosmia, and ageusia was tested and found positive for SARS-CoV-2 through a pharyngeal swab. Eight days after he provided semen and urine samples in which viral RNA presence was measured using a Real time RT PCR system (RealStar SARS-CoV-2 RT-PCR, Altona Diagnostics) targeting E and S viral genes. Results and discussion Semen and urine samples search for SARS-CoV-2 RNA was negative. Although this should be interpreted cautiously, it may be possible that either the viral clearance kinetics in these matrices matches the progressive clinical recovery of the patient or that the virus was never present in these fluids at the time of the laboratory diagnosis.